Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
27 studies found for:    " May 29, 2007":" June 29, 2007"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" May 29, 2007":" June 29, 2007"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Microbicides Acceptability Among Sexually Active Young Women
Condition: HIV Infections
Intervention: Behavioral: Automated diary system
2 Completed HIV Prevention in Haitian American Adolescents
Condition: HIV Infections
Intervention: Behavioral: Cognitive Behavioral and Standard Care with Healthy Living
3 Completed Study to Compare the Immunogenicity and Safety of Two HIV Preventive Vaccinations in Healthy Volunteers
Condition: HIV Infections
Interventions: Biological: DNA-C;   Biological: NYVAC-C
4 Completed
Has Results
Pharmacokinetic Interactions Between Buprenorphine and Tipranavir/Ritonavir
Condition: HIV Infections
Intervention: Drug: Buprenorphine, Tipranavir and ritonavir
5 Completed Expanded Characterization of Immune Response to Merck Adenovirus 5 Gag/Pol/Nef Vaccine Given to HIV Uninfected Adults
Condition: HIV Infections
Intervention: Biological: MRKAd5 HIV-1 gag/pol/nef
6 Completed Engaging Care for HIV-infected Adolescent Females.
Condition: HIV Infection
Interventions: Behavioral: Quantitative Interview;   Behavioral: Ethnographic Interview;   Behavioral: Gender Interview
7 Completed Project HERMITAGE: HIV Prevention in Hospitalized Russian Drinkers
Condition: HIV Infections
Interventions: Behavioral: Individual and group HIV risk behavior counseling sessions;   Behavioral: health education and support group
8 Completed Safety and Immunogenicity Study of tgAAC09, a Gag-PR-RT AAV HIV Vaccine
Condition: HIV Infection
Intervention: Biological: tgAAC09
9 Completed
Has Results
Preservation and Expansion of T-cell Subsets Following HAART De-intensification to Atazanavir/Ritonavir (ATV/r)
Condition: HIV Infections
Interventions: Procedure: Early Initiation of Highly Active Anti-Retroviral Therapy;   Procedure: Standard Care
10 Terminated
Has Results
A Study of Fuzeon (Enfuvirtide) With an Integrase Inhibitor Plus Optimized Background in Treatment-Experienced HIV-1 Infected Patients
Condition: HIV Infections
Interventions: Drug: enfuvirtide [Fuzeon];   Drug: Optimized background ARV;   Drug: Integrase inhibitor
11 Active, not recruiting
Has Results
Safety and Pharmacokinetics (PK) of Raltegravir in HIV (Human Immunodeficiency Virus)-Infected Children and Adolescents
Condition: HIV Infections
Interventions: Drug: Raltegravir poloxamer film coated tablet;   Drug: Raltegravir chewable tablet;   Drug: Raltegravir oral granules for suspension (20 mg/mL)
12 Completed Trial Comparing Three Strategies of Vaccination Against the Virus of Hepatitis B in HIV Infected Patients
Condition: HIV Infections
Intervention: Biological: GenHevac B Pasteur
13 Completed
Has Results
A Study to Evaluate the Safety and Efficacy of Adding Enfuvirtide to Oral Highly Active Antiretroviral Therapy (HAART) in Human Immunodeficiency Virus (HIV) Patients With Prior Treatment Experience
Condition: HIV Infections
Interventions: Drug: Enfuvirtide;   Drug: Highly active antiretroviral treatment (HAART)
14 Completed An Open Label Non-Randomized Dose Escalating Trial to Assess Safety and Tolerability of Alb-Interferon Alfa 2b Every Two Weeks With Ribavirin Among HIV/HCV Coinfected Individuals
Conditions: HIV Infections;   HCV
Interventions: Drug: Albinterferon;   Drug: Ribavirin;   Drug: Albuferon
15 Completed Effects of Creatine and Resistance Exercise Training in People With HIV Infection
Condition: HIV Infections
Interventions: Procedure: Use of creatine monohydrate (a dietary supplement);   Behavioral: Progressive resistance exercise training
16 Completed A Study of MVA85A, in Asymptomatic Volunteers Infected With TB, HIV or Both
Conditions: HIV Infections;   TB
Intervention: Biological: MVA 85A
17 Withdrawn Safety And Efficacy Study Of CP-675,206 In HIV-Infected Patients
Condition: Human Immunodeficiency Virus
Intervention: Drug: CP-675,206
18 Completed Efavirenz-based Versus Nevirapine-based Antiretroviral Therapy Among HIV-infected Patients Receiving Rifampin
Conditions: HIV Infections;   Tuberculosis
Interventions: Drug: efavirenz;   Drug: nevirapine
19 Completed Effects of HIV and Hepatitis C Virus on the Brain
Conditions: HIV Infections;   Hepatitis C
Intervention:
20 Completed A Study of the Drug Interactions Between a Hormonal Emergency Contraception and an HIV Medication
Conditions: HIV Infections;   Contraception;   Pharmacokinetics
Intervention: Drug: levonorgestrel, efavirenz

   Previous Page Studies Shown (1-20) Next Page (21-27) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.